logo

Breaking News

Share SHARE

Michael Kors Holdings Limited (KORS), a global fashion luxury brand, said that it has reached an agreement to acquire Jimmy Choo PLC (CHOO.L), a premier global luxury footwear and accessories brand. As per the terms of the transaction, Jimmy Choo shareholders will receive 230 pence per share, with an...

Domino's Pizza Group PLC (DOM.L) reported that its first-half pretax profit increased year-over-year to 46.23 million pounds from 40.87 million pounds in the same period last year. Profit for the period from continuing operations rose to 37.65 million pounds from 33.03 million pounds last year. Earnings...

Cott Corp. (COT, BCB.TO) said it has entered into a definitive agreement to sell its traditional beverage manufacturing business, Cott Beverages, to Refresco for $1.25 billion. The company expects the transaction will shift its core focus to the growing categories of water, coffee, tea and filtration. Refresco...

Aixtron SE (AIXG), a provider of deposition equipment to the semiconductor industry, reported Tuesday that its first-half net result was a loss of 24.9 million euros, compared to loss of 26.6 million euros a year ago. Adjusted loss in the latest period was 10.4 million euros. Earnings before interest...

Dutch paints and chemicals maker AkzoNobel N.V. (AKZA.AS, AKZOY) said it has convened an Extraordinary General Meeting of Shareholders or EGM, to be held at Hilton Hotel in Amsterdam, the Netherlands, on Friday, September 8, 2017. The agenda items include the appointment of T.F.J. Vanlancker as member...

Norwegian aluminium producer Norsk Hydro AS (NHY, NHYDY.PK, NHYDY.PK) reported Tuesday that its second-quarter net income amounted to 1.562 billion Norwegian kroner, down 25 percent from 2.08 billion kroner last year. Earnings per share fell 24 percent to 0.73 krone. Underlying net income was 2.21...

Unibail-Rodamco SE (UNBLF.PK) reported that its first-half net result to owners of the parent increased to 1.46 billion euros from 1.28 billion euros, prior year. Net result for the period per share was 14.0 euros compared to 12.4 euros. Recurring net result increased to 614 million euros from 575 million...

Merck (MRK) reported that the pivotal phase 3 KEYNOTE-040 trial investigating KEYTRUDA (pembrolizumab), the company's anti-PD-1 therapy, in previously treated patients with recurrent or metastatic head and neck squamous cell carcinoma did not meet its pre-specified primary endpoint of overall survival....

HNI Corp. (HNI) announced the Corporation estimates full year non-GAAP earnings per share to be in the range of $2.35 to $2.55, which excludes restructuring and transition costs. Full year organic sales are expected to be up 2 to 5 percent. Including the impacts of acquisitions and divestitures, full...

Novavax, Inc. (NVAX) announced positive topline data from its Phase 2 safety and immunogenicity trial of the RSV F Vaccine in older adults, new preclinical data on its RSV F Vaccine construct, additional findings from the prior Phase 2 and Phase 3 clinical trials in older adults, and an operational update...

Hexcel Corp. (HXL) announced the company's Board has approved a 13.6 percent increase in quarterly cash dividend rate to $0.125 per common share. The dividend is payable on August 10, 2017 to stockholders of record as of August 3, 2017. Hexcel Corp. also revised its full year sales outlook to be...

QEP Resources, Inc. (QEP) announced its subsidiary, QEP Energy Company, has entered into two definitive agreements to sell natural gas assets in southwest Wyoming for combined proceeds of $777.5 million. The first agreement provides for the sale of all of QEP's assets in the Pinedale Anticline field...

Hibbett Sports Inc. (HIBB) said that it expects comparable store sales to decrease approximately 10% for the second quarter ending July 29, 2017, citing very challenging sales trends. In the pre-Market trade, HIBB is trading at $15.10, down $4.60 or 23.35 percent. The decline in sales, along with...

Pfizer Inc. (PFE) said that the REFLECTIONS B7391003 study, a comparative, confirmatory safety and efficacy study of PF-06439535 versus Avastin (bevacizumab), met its primary objective. PF-06439535 is being developed by Pfizer as a potential biosimilar to Avastin. The trial demonstrated equivalence...

Merck & Co. Inc. (MRK) announced Monday the U.S. launch of RENFLEXIS (infliximab-abda), a biosimilar of the originator biologic medicine Remicade (infliximab). RENFLEXIS was approved by the U.S. Food and Drug Administration on April 21 for all eligible indications. RENFLEXIS is the first medicine...

Follow RTT